Literature DB >> 20471112

LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes?

Tatjana Singer1, Michael J McConnell, Maria C N Marchetto, Nicole G Coufal, Fred H Gage.   

Abstract

LINE-1 (L1) elements are retrotransposons that insert extra copies of themselves throughout the genome using a 'copy and paste' mechanism. L1s comprise nearly approximately 20% of the human genome and are able to influence chromosome integrity and gene expression upon reinsertion. Recent studies show that L1 elements are active and 'jumping' during neuronal differentiation. New somatic L1 insertions could generate 'genomic plasticity' in neurons by causing variation in genomic DNA sequences and by altering the transcriptome of individual cells. Thus, L1-induced variation could affect neuronal plasticity and behavior. We discuss potential consequences of L1-induced neuronal diversity and propose that a mechanism for generating diversity in the brain could broaden the spectrum of behavioral phenotypes that can originate from any single genome. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471112      PMCID: PMC2916067          DOI: 10.1016/j.tins.2010.04.001

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  83 in total

1.  Environmental factors affecting transcription of the human L1 retrotransposon. I. Steroid hormone-like agents.

Authors:  José F Morales; Elizabeth T Snow; John P Murnane
Journal:  Mutagenesis       Date:  2002-05       Impact factor: 3.000

2.  Genomic deletions created upon LINE-1 retrotransposition.

Authors:  Nicolas Gilbert; Sheila Lutz-Prigge; John V Moran
Journal:  Cell       Date:  2002-08-09       Impact factor: 41.582

3.  The significance of responses of the genome to challenge.

Authors:  B McClintock
Journal:  Science       Date:  1984-11-16       Impact factor: 47.728

4.  Exercise enhances learning and hippocampal neurogenesis in aged mice.

Authors:  Henriette van Praag; Tiffany Shubert; Chunmei Zhao; Fred H Gage
Journal:  J Neurosci       Date:  2005-09-21       Impact factor: 6.167

5.  Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition.

Authors:  Q Feng; J V Moran; H H Kazazian; J D Boeke
Journal:  Cell       Date:  1996-11-29       Impact factor: 41.582

6.  A mouse model of human L1 retrotransposition.

Authors:  Eric M Ostertag; Ralph J DeBerardinis; John L Goodier; Yue Zhang; Nuo Yang; George L Gerton; Haig H Kazazian
Journal:  Nat Genet       Date:  2002-11-04       Impact factor: 38.330

7.  L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells.

Authors:  Nuo Yang; Haig H Kazazian
Journal:  Nat Struct Mol Biol       Date:  2006-08-27       Impact factor: 15.369

8.  DNA methylation of retrotransposon genes is regulated by Piwi family members MILI and MIWI2 in murine fetal testes.

Authors:  Satomi Kuramochi-Miyagawa; Toshiaki Watanabe; Kengo Gotoh; Yasushi Totoki; Atsushi Toyoda; Masahito Ikawa; Noriko Asada; Kanako Kojima; Yuka Yamaguchi; Takashi W Ijiri; Kenichiro Hata; En Li; Yoichi Matsuda; Tohru Kimura; Masaru Okabe; Yoshiyuki Sakaki; Hiroyuki Sasaki; Toru Nakano
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

9.  Elevated presence of retrotransposons at sites of DNA double strand break repair in mouse models of metabolic oxidative stress and MYC-induced lymphoma.

Authors:  Lynne D Rockwood; Klaus Felix; Siegfried Janz
Journal:  Mutat Res       Date:  2004-04-14       Impact factor: 2.433

10.  Selection of target sites for mobile DNA integration in the human genome.

Authors:  Charles Berry; Sridhar Hannenhalli; Jeremy Leipzig; Frederic D Bushman
Journal:  PLoS Comput Biol       Date:  2006-11-24       Impact factor: 4.475

View more
  124 in total

Review 1.  Neurodegeneration the RNA way.

Authors:  Abigail J Renoux; Peter K Todd
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

2.  Stem cells: Troublesome memories.

Authors:  Thomas P Zwaka
Journal:  Nature       Date:  2010-09-16       Impact factor: 49.962

3.  Neuroepigenomics: Resources, Obstacles, and Opportunities.

Authors:  John S Satterlee; Andrea Beckel-Mitchener; Roger Little; Dena Procaccini; Joni L Rutter; Amy C Lossie
Journal:  Neuroepigenetics       Date:  2015-01-01

Review 4.  The role of transposable elements in health and diseases of the central nervous system.

Authors:  Matthew T Reilly; Geoffrey J Faulkner; Joshua Dubnau; Igor Ponomarev; Fred H Gage
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

Review 5.  Investigating somatic aneuploidy in the brain: why we need a new model.

Authors:  Jimi L Rosenkrantz; Lucia Carbone
Journal:  Chromosoma       Date:  2016-09-16       Impact factor: 4.316

6.  An epi [c] genetic battle: LINE-1 retrotransposons and intragenomic conflict in humans.

Authors:  Martin Muñoz-Lopez; Angela Macia; Marta Garcia-Cañadas; Richard M Badge; Jose L Garcia-Perez
Journal:  Mob Genet Elements       Date:  2011-07-01

7.  Mosaic copy number variation in human neurons.

Authors:  Michael J McConnell; Michael R Lindberg; Kristen J Brennand; Julia C Piper; Thierry Voet; Chris Cowing-Zitron; Svetlana Shumilina; Roger S Lasken; Joris R Vermeesch; Ira M Hall; Fred H Gage
Journal:  Science       Date:  2013-11-01       Impact factor: 47.728

Review 8.  Surprising origins of sex differences in the brain.

Authors:  Margaret M McCarthy; Lindsay A Pickett; Jonathan W VanRyzin; Katherine E Kight
Journal:  Horm Behav       Date:  2015-04-25       Impact factor: 3.587

Review 9.  Unveiling Human Non-Random Genome Editing Mechanisms Activated in Response to Chronic Environmental Changes: I. Where Might These Mechanisms Come from and What Might They Have Led To?

Authors:  Loris Zamai
Journal:  Cells       Date:  2020-10-27       Impact factor: 6.600

10.  Diagnosing and Treating Nervous System Disorders by Targeting Novel Classes of Non-coding RNAs.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Int Drug Discov       Date:  2011 Jun-Jul
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.